Approval · Notice of Compliance 33868 · 2024
NEXAVAR: Notice of Compliance 33868
Issued August 26, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33868
- Date
- August 26, 2024
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXAVAR | Not yet assigned | — |
Medicinal ingredients
- SORAFENIB TOSYLATE 200 MG per TAB